← Leaderboards
Dustin J Maly
University Of Washington
$15,468,910
Attributed
$23,798,164
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,798,164 · 12
By mechanism
R01$18,959,378 · 8
U01$3,748,892 · 2
R21$1,089,894 · 2
Top collaborators
- Feroz R Papa21 shared
- Bradley J Backes5 shared
- Shao-En Ong5 shared
- Wesley C Van Voorhis4 shared
- Michael H Gelb2 shared
Most similar at University Of Washington
Same institution · by research overlap
- David R Morris$5,870,409
- Shao-En Ong$5,152,746
- Zachary Eugene Potter$74,161
Others in their field
Top investigators on “Phosphotransferases”
- David Heimbrook · Leidos Biomedical Research, Inc.$26,594,235
- Gary L. Johnson · National Jewish Health$21,727,284
- Peter Karl Sorger · Massachusetts Institute Of Technology$20,231,592
- Lewis C Cantley · Beth Israel Deaconess Medical Center$19,866,259
- Richard L Huganir · Johns Hopkins University$18,390,405
- Fulton T Crews · University Of North Carolina Chapel Hill$17,915,277
Research focus
PhosphotransferasesCellsKinase InhibitorSmall MoleculeResponseSignal TransductionMolecular ConformationProteinsEnzymesAffectPharmaceutical PreparationsInhibitor/AntagonistDiabetes MellitusInflammationMalignant NeoplasmsSignal PathwayPathway InteractionsBinding SitesMolecularChemical GeneticsMutantChronicBaseDesign
Grant awards (61)
Driving next generation UPR inhibitory kinase inhibitors for T1D$816,325
U01 · FY2025 · DK
Disease-modifying drugs for T2D through targeting the Unfolded Protein Response$667,957
R01 · FY2025 · DK
Massively Parallel Biochemical Annotation of Missense DNA Variants to Support Newborn Screening by Whole Genome Sequencing$643,802
R01 · FY2025 · HD
Chemical biological analysis of RAF Kinases$497,519
R01 · FY2025 · CA · contact PI
Chemical Genetic Analysis of RAS Signaling$327,812
R01 · FY2025 · GM · contact PI
New Molecular Probes For Protein Kinases$327,602
R01 · FY2025 · GM · contact PI
Disease-modifying drugs for T2D through targeting the Unfolded Protein Response$683,334
R01 · FY2024 · DK
Massively Parallel Biochemical Annotation of Missense DNA Variants to Support Newborn Screening by Whole Genome Sequencing$578,935
R01 · FY2024 · HD
Chemical biological analysis of RAF Kinases$508,660
R01 · FY2024 · CA · contact PI
New Molecular Probes For Protein Kinases$327,887
R01 · FY2024 · GM · contact PI
Chemical Genetic Analysis of RAS Signaling$327,812
R01 · FY2024 · GM · contact PI
Chemical Genetic Analysis of RAS Signaling$41,106
R01 · FY2024 · GM · contact PI
New Molecular Probes For Protein Kinases$328,166
R01 · FY2023 · GM · contact PI
Chemical Genetic Analysis of RAS Signaling$327,812
R01 · FY2023 · GM · contact PI
New Molecular Probes For Protein Kinases$102,350
R01 · FY2023 · GM · contact PI
Chemical Genetic Analysis of RAS Signaling$82,215
R01 · FY2023 · GM · contact PI
Partial Antagonists of IRE1 RNase--'PAIR's--to treat Type 1 Diabetes$720,903
U01 · FY2022 · DK
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2022 · DK
New Molecular Probes For Protein Kinases$328,436
R01 · FY2022 · GM · contact PI
Chemical Genetic Analysis of RAS Signaling$327,812
R01 · FY2022 · GM · contact PI
Chemical Genetic Analysis of RAS Signaling$41,109
R01 · FY2022 · GM · contact PI
Partial Antagonists of IRE1 RNaseâÂÂâÂÂPAIRâÂÂsâÂÂto treat Type 1 Diabetes$726,915
U01 · FY2021 · DK
Interrogation of the Roles of Tyrosine Kinases in the Unfolded Protein Response$525,712
R01 · FY2021 · DK · contact PI
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2021 · DK
New Molecular Probes For Protein Kinases$317,780
R01 · FY2021 · GM · contact PI
Partial Antagonists of IRE1 RNaseâÂÂâÂÂPAIRâÂÂsâÂÂto treat Type 1 Diabetes$732,753
U01 · FY2020 · DK
Interrogation of the Roles of Tyrosine Kinases in the Unfolded Protein Response$537,083
R01 · FY2020 · DK · contact PI
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2020 · DK
New Molecular Probes For Protein Kinases$317,780
R01 · FY2020 · GM · contact PI
Partial Antagonists of IRE1 RNaseââPAIRâsâto treat Type 1 Diabetes$751,996
U01 · FY2019 · DK
Interrogation of the Roles of Tyrosine Kinases in the Unfolded Protein Response$548,120
R01 · FY2019 · DK · contact PI
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2019 · DK
New Molecular Probes For Protein Kinases$317,780
R01 · FY2019 · GM · contact PI
Interrogation of the roles of tyrosine kinases in the unfolded protein response$572,485
R01 · FY2018 · DK · contact PI
Developing UPR inhibitory KIRAs into oral antidiabetic beta cell-sparing drugs$502,298
R01 · FY2018 · DK
New Molecular Probes For Protein Kinases$317,473
R01 · FY2018 · GM · contact PI
New Molecular Probes For Protein Kinases$90,000
R01 · FY2018 · GM · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$539,154
R01 · FY2017 · DK
Discovery and validation of new kinase drug targets in T. brucei$407,294
R01 · FY2017 · AI · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$489,432
R01 · FY2016 · DK
Discovery and validation of new kinase drug targets in T. brucei$404,532
R01 · FY2016 · AI · contact PI
New Molecular Probes For Protein Kinases$303,593
R01 · FY2016 · GM · contact PI
Pharmacological Validation of IRE1 for Diabetes Mellitus$72,656
R01 · FY2016 · DK
Pharmacological Validation of IRE1 for Diabetes Mellitus$488,979
R01 · FY2015 · DK
Discovery and validation of new kinase drug targets in T. brucei$404,743
R01 · FY2015 · AI · contact PI
New Molecular Probes For Protein Kinases$303,593
R01 · FY2015 · GM · contact PI
Kinase Profiling with Quantititative Chemoproteomics$201,623
R21 · FY2015 · CA
Target identification by small-molecule labeling in live cells$193,125
R21 · FY2015 · EB
Pharmacological Validation of IRE1 for Diabetes Mellitus$501,998
R01 · FY2014 · DK
Discovery and validation of new kinase drug targets in T. brucei$404,853
R01 · FY2014 · AI · contact PI
New Molecular Probes For Protein Kinases$303,593
R01 · FY2014 · GM · contact PI
Target identification by small-molecule labeling in live cells$231,750
R21 · FY2014 · EB
Kinase Profiling with Quantititative Chemoproteomics$228,170
R21 · FY2014 · CA
New Molecular Probes For Protein Kinases$303,593
R01 · FY2013 · GM · contact PI
Kinase Profiling with Quantititative Chemoproteomics$235,226
R21 · FY2013 · CA
New Molecular Probes for Protein Kinases$274,743
R01 · FY2012 · GM · contact PI
New Molecular Probes for Protein Kinases$276,602
R01 · FY2011 · GM · contact PI
New Molecular Probes for Protein Kinases$281,150
R01 · FY2010 · GM · contact PI
New Molecular Probes for Protein Kinases$99,999
R01 · FY2010 · GM · contact PI
New Molecular Probes for Protein Kinases$285,647
R01 · FY2009 · GM · contact PI
New Molecular Probes for Protein Kinases$287,195
R01 · FY2008 · GM · contact PI